Invention Grant
US08975223B2 Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146
有权
用包含SEQ ID No.146的氨基酸序列的肽治疗代谢紊乱和肥胖症的方法
- Patent Title: Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146
- Patent Title (中): 用包含SEQ ID No.146的氨基酸序列的肽治疗代谢紊乱和肥胖症的方法
-
Application No.: US13996937Application Date: 2011-12-22
-
Publication No.: US08975223B2Publication Date: 2015-03-10
- Inventor: Louis Vignati , Richard D. DiMarchi
- Applicant: Louis Vignati , Richard D. DiMarchi
- Applicant Address: US NJ Nutley
- Assignee: Marcadia Biotech, Inc.
- Current Assignee: Marcadia Biotech, Inc.
- Current Assignee Address: US NJ Nutley
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2011/066739 WO 20111222
- International Announcement: WO2012/088379 WO 20120628
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P3/10 ; A61K31/195 ; A61K31/198 ; A61K45/06
Abstract:
Methods are provided for administering an extended half-life GLP-1/GIP coagonist peptide to a patient in need thereof for reducing weight gain, inducing weight loss, treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels in said patient.
Public/Granted literature
Information query
IPC分类:
